+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07539311

Phase 2 Open-label Study of Rina-S Monotherapy in Advanced Gastrointestinal Cancer Patients

Led by Genmab · Updated on 2026-11-03

160

Participants Needed

28

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of Rina-S as a monotherapy treatment for advanced gastrointestinal GI cancers in participants who have progressed after standard treatments. This Phase 2, open-label study involves multiple cohorts across various countries and focuses on participants with metastatic or unresectable GI cancer who meet specific health criteria. Participants will receive Rina-S through intravenous administration at doses specified for different cohorts. All participants will receive the active drug no placebo is involved. The treatment cycles last 21 days, with 1 to 5 visits per cycle. Treatment may continue as long as the cancer remains stable or improves and the study is ongoing. The average treatment period is expected to be about 12 months, within an overall average study duration of 22 months that includes data collection before and after treatment. During the study, participants will have regular visits for safety monitoring and assessments, including blood tests, heart activity recordings, and imaging such as X-rays. Researchers will measure outcomes like tumor response, disease control, progression-free survival, and treatment-related adverse events. Pharmacokinetics of Rina-S will also be studied. Participants health will be closely observed throughout the study duration, which may last up to 22 months.

CONDITIONS

Brief Title

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

Research Team

G

Genmab Trial Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here